Navigation Links
Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured''

WASHINGTON--(BUSINESS WIRE)--May 21, 2007 - Results from a new study, presented at the 38th annual Digestive Disease Week (DDW) conference, showed that more than 99 percent of patients with chronic hepatitis C virus (HCV) infection who were treated successfully with PEGASYS(R) (peginterferon alfa-2a) had no detectable virus up to seven years later - validating the use of the word "cured" to describe these patients, according to study authors. Currently, the best indicator of treatment success is a sustained viral response (SVR), defined as undetectable hepatitis C virus in the blood six months after the end of treatment. The results announced today are from a long-term follow-up study to determine whether the virus re-emerges in patients who achieve an SVR. (Studies show that, overall, about half of patients with hepatitis C monoinfection can achieve an SVR with PEGASYS and ribavirin treatment, the current standard of care.)

"The results announced today are encouraging because it is rare in the treatment of life-threatening viral diseases that can we tell patients they have the chance for a cure," said Dr. Mitchell L. Shiffman, Professor of Medicine, Chief of Hepatology and Medical Director of the Liver Transplant Program, Virginia Commonwealth University Medical Center, and study author. "But in hepatitis C today, we are able to help some patients achieve an outcome that effectively enables them to put their disease behind them."

About the Study (Abstract ID #444)

This study monitored 997 patients (either mono-infected with chronic HCV or co-infected HCV and HIV) who achieved an SVR following treatment with PEGASYS monotherapy or combination therapy with PEGASYS and ribavirin. Serum levels of HCV were monitored on an annual basis for an average of 4.1 years (range 0.4 to 7 years) following successful treatment. Of the 997 patients, 989 (greater than 99 percent) maintained undetectable levels of H
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Post Your Comments:
(Date:3/30/2015)... -- Edelberg & Associates (EA) and ScribeAmerica today are ... coding software platform designed to engage and successfully ... at the point of care.  In a significant ... successfully built, deployed and tested a new proprietary ... medical coder that can radically improve natural latencies ...
(Date:3/30/2015)... March 30, 2015 DURECT Corporation (Nasdaq: ... initiated a multi-dose Phase 1 clinical trial of ... in DURECT,s Epigenomic Regulator Program.  DUR-928 is an ... have broad applicability in metabolic diseases such as ... (NASH).  It may also play an important role ...
(Date:3/30/2015)... --  GlassesUSA , the online retailer specializing in prescription ... financing led by Viola Private Equity , a member ... business growth and accelerate their expansion as a leading player ... and B2B. GlassesUSA was founded in 2009 by ... and CTO Roy Yamner . Leveraging their vast experience ...
Breaking Medicine Technology:Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... complained for years about the mental fog known ... University, researchers have discovered,that injections of N-acetyl cysteine ... breast cancer chemotherapy drugs sometimes induce., In ... issue of the,journal Metabolic Brain Disease, rats were ...
... 4 Cytopia Limited (ASX:,CYT) today announced that ... of CYT997, the company,s novel vascular-disrupting anticancer agent,in ... known as glioblastoma,multiforme (GBM)., The GBM clinical ... in highly,vascular, solid tumor indications for the company ...
Cached Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a sleek single-serve ... for reuse. Consumers simply twist the cup, turn it upward ... and basically anyone can now enjoy a non-alcoholic wine ... or pair with meals at work, home, or wherever the ... and that means Napa Wine grapes undergo the traditional wine ...
(Date:3/30/2015)... Clemente, CA (PRWEB) March 30, 2015 South ... organization as a Surety Bond Representative. Richard has been known ... over a decade. , Richard attended the University of Georgia, ... nearly four decades in the sales and sales management of ... 500 companies. , Most recently, Richard was a senior ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Considered to ... compliance (GRC) in the global business community, this next ... ups the ante by managing big data and frameworks ... with the already powerful analytic and logic features are ... Peters, CEO of Lazarus Alliance said “The IT Audit ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 ... recognized designer and manufacturer of ergonomic seating ... upholstery options. The new upholsteries bolster the ... and custom seating, providing disinfectable, green choices. ... by renowned textile purveyor CF Stinson. Six ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Pro Ace ... the company will now provide qualified HVAC technicians that ... their heat pumps and related systems throughout Vancouver, North ... furnaces and air conditioners, heat pumps require regular maintenance ... experts such as BC Hydro strongly suggest you have ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2
... ... , ... -- You, Me and Tea is pleased to announce the launch of their new website, ... and Sri Lanka and specializes in the retailing of India,s world-renowned teas (Darjeeling, Assam and Nilgiri) ...
... , Collaboration of Statewide and Local Health Information ... Departments , SAN FRANCISCO, Oct. 14 The ... system is live in Orange County at Coastal Communities ... the local HIE effort, the Orange County Partnership Regional ...
... 14 The American Academy of Physician Assistants ... in the United States, applauds the Senate Finance ... Act. AAPA is committed to seeking health ... with access to quality, affordable, cost-effective health care. ...
... , WASHINGTON, Oct. 14 Waters Corporation (NYSE: WAT ... Forum with the Center for Science in the Public Interest ... from around the globe to discuss solutions that improve food ... , "Food safety is an important segment of ...
... ordered for these end-stage patients, researchers say, , WEDNESDAY, ... dementia as affecting only the mind, but a new ... eventually fatal. , The misconception by family members ... condition can have negative consequences for the patient, the ...
... and well-being in study patients , WEDNESDAY, Oct. 14 ... undergoing chemotherapy can reduce fatigue and boost muscle strength, ... , Fatigue is one of the most frequent and ... , The new study included 269 cancer patients, aged ...
Cached Medicine News:Health News:You, Me and Tea is Pleased to Announce the Website Debut of youmeandtea.com 2Health News:First Site in CalRHIO's Statewide Health Information Exchange Goes Live in Orange County 2Health News:First Site in CalRHIO's Statewide Health Information Exchange Goes Live in Orange County 3Health News:American Academy of Physician Assistants Applauds Senate Finance Committee for Advancing Health Reform Legislation 2Health News:At Waters Forum, Rep. DeLauro, Administration Urge Congress to Improve the Safety of Imported Food 2Health News:At Waters Forum, Rep. DeLauro, Administration Urge Congress to Improve the Safety of Imported Food 3Health News:Families Need to Know When Dementia Becomes Terminal 2Health News:Families Need to Know When Dementia Becomes Terminal 3
... single use suturing device has application ... of interrupted or running stitches in ... use suturing device is available in ... with the choice of 4 suture ...
... of a 42" long suture inserted into a ... one end and scored on the other. The ... to a ST-3 needle. The opposite end of ... of the plastic tube. The scored end acts ...
This ENDOLOOP suture has a suture type - 0 MONOCRYL and a 1.5 inch diameter....
... inserted into a plastic tube. The plastic tube is ... The suture protrudes from the narrow end and is ... becomes secure after the device is activated. The opposite ... end of the plastic tube. The scored end acts ...
Medicine Products: